Aufklappen
Schliessen
Branche PharmaAktienmarkt NASDAQ Biotech |
|
|
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
| Leser | Medien | |
|---|---|---|---|---|
| Di | Horizon Therapeutics plc to Release Second-Quarter 2019 Financial Results and Host Webcast on Aug. 7, 2019 | 6 | Business Wire | |
| Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its second-quarter 2019 financial results will be released on Wednesday, Aug. 7, 2019. Following the announcement, Horizon's management... ► Artikel lesen | ||||
| Fr | Horizon Therapeutics Files BLA to FDA for Eye Disease Drug | 2 | Zacks | |
► Artikel lesen | ||||
| HORIZON THERAPEUTICS Aktien ab 5,80 Euro handeln - Ohne versteckte Kosten! | LYNX | |||
► Artikel lesen | ||||
| Fr | Horizon Therapeutics Public Ltd Co - 8-K, Current Report | 1 | SEC Filings | |
► Artikel lesen | ||||
| 11.07. | Horizon Therapeutics plc Announces Pricing of Private Offering of Senior Notes | 8 | Business Wire | |
| Horizon Therapeutics plc (Nasdaq: HZNP) ("Horizon") today announced that Horizon Pharma USA, Inc., its wholly-owned subsidiary, has priced its offering of $600 million aggregate principal amount of... ► Artikel lesen | ||||
| 10.07. | Horizon Therapeutics announces proposed private offering of senior notes | 2 | Seeking Alpha | |
► Artikel lesen | ||||
| 10.07. | Horizon Pharma USA, Inc. -- Moody's assigns B1 to Horizon's new sr. unsecured notes | 1 | Moody's Ratings | |
► Artikel lesen | ||||
| 10.07. | Horizon Therapeutics plc Announces Proposed Private Offering of Senior Notes | 4 | Business Wire | |
| Horizon Therapeutics plc (Nasdaq: HZNP) today announced that Horizon Pharma USA, Inc., its wholly-owned subsidiary, intends, subject to market and other considerations, to offer $500 million aggregate... ► Artikel lesen | ||||
| 10.07. | Horizon Therapeutics plc Submits Teprotumumab Biologics License Application (BLA) for the Treatment of Active Thyroid Eye Disease (TED) | 9 | Business Wire | |
| Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its investigational medicine... ► Artikel lesen | ||||
| 21.06. | Horizon Therapeutics initiates MIRROR trial evaluating KRYSTEXXA in combination with methotrexate | 2 | Pharmaceutical Business Review | |
► Artikel lesen | ||||
| 20.06. | Horizon Therapeutics plc Initiates MIRROR Randomized Controlled Trial Evaluating KRYSTEXXA (pegloticase injection) in Combination with Methotrexate to Increase Response Rates and Duration of Therapy | 7 | Business Wire | |
| - Approach informed by regulatory guidance and real-world clinical experience -
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the initiation of a clinical trial evaluating KRYSTEXXA (pegloticase... ► Artikel lesen | ||||
| 12.06. | Horizon Therapeutics plc Highlights the Systemic Implications of Gout and the Need for Improved Patient Care Strategies with a Series of Presentations at EULAR 2019 | 15 | Business Wire | |
| - Poster presentations raise critical systemic correlations central to optimizing patient care - - Oral presentation illustrates novel monitoring tool designed to track response... ► Artikel lesen | ||||
| 04.06. | Horizon Therapeutics plc to Participate in the JMP Securities Life Sciences Conference | 7 | Business Wire | |
| Horizon Therapeutics plc (Nasdaq: HZNP), today announced that the company will participate in the following conference in June: The JMP Securities Life Sciences Conference ... ► Artikel lesen | ||||
| 29.05. | Horizon Therapeutics plc and Invitae Corporation Launch Urea Cycle Disorder Genetic Testing Program | 8 | Business Wire | |
| -- New program improves access and speed to receiving a diagnosis for people and extended family members who may be living with Urea Cycle Disorders -- Horizon Therapeutics plc (Nasdaq:... ► Artikel lesen | ||||
| 22.05. | Horizon Therapeutics Public Ltd Co - 8-K, Current Report | 2 | SEC Filings | |
► Artikel lesen | ||||
| 16.05. | Horizon Therapeutics plc Launches New Data-Driven Campaign to Reset the Dialogue on Gout | 5 | Business Wire | |
| -- Research that has redefined the trajectory and true impact of the disease underscores the campaign -- Horizon Therapeutics plc (Nasdaq: HZNP) today announced the launch of Gout ... ► Artikel lesen | ||||
| 15.05. | Horizon Pharma USA, Inc. -- Moody's assigns Ba1 rating to Horizon's senior secured term loan | 2 | Moody's Ratings | |
► Artikel lesen | ||||
| 09.05. | Horizon Therapeutics' (HZNP) Q1 Earnings Beat Estimates | 3 | Zacks | |
► Artikel lesen | ||||
| 09.05. | Horizon Therapeutics plc Announces Tina Ventura as a Healthcare Businesswomen's Association 2019 Luminary | 5 | Business Wire | |
| Horizon Therapeutics plc (Nasdaq: HZNP) announced today that Tina Ventura, senior vice president, investor relations, has been named a 2019 Healthcare Businesswomen's Association (HBA) Luminary.... ► Artikel lesen | ||||
| 08.05. | Here's How Horizon Therapeutics Blew Past Wall Street Estimates in Q1 | - | The Motley Fool | |
► Artikel lesen | ||||
| 08.05. | Horizon Therapeutics PLC (HZNP) CEO Tim Walbert on Q1 2019 Results - Earnings Call Transcript | - | Seeking Alpha | |
► Artikel lesen | ||||
Seite:
1 2 3 4 Weiter >>
78 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | |
|---|---|---|---|---|
| BAYER | 59,02 | +0,02 % | Bayer Aktie: Kommt die komplette Neubewertung? | |
| Nach dem jüngsten Kurssprung hat die Bayer Aktie eine Konsolidierungspause eingelegt. Dem Sprung von 52,08 Euro auf Anfang Juli erreichte 62,19 Euro folgte in den letzten Tagen eine Abwärtsbewegung... ► Artikel lesen | ||||
| NOVARTIS | 83,58 | +3,50 % | Der nächste Alzheimer-Rückschlag: Novartis und Amgen stellen Forschungsprojekt ein | |
| Schon wieder ein herber Rückschlag in der Alzheimer-Forschung. Diesmal traf es ein gemeinsames Forschungsprojekt (der BACE1-Inhibitor CNP520) der Schweizer mit Amgen und dem Banner Alzheimer Institut.... ► Artikel lesen | ||||
| NOVO NORDISK | 42,99 | -0,61 % | NOVO NORDISK A S - 6-K, Report of foreign issuer | |
► Artikel lesen | ||||
| MERCK KGAA | 94,02 | +1,45 % | Merck's Embracing Carers Launches 'Time Counts' to Raise 1 Million Minutes of Support for Carers | |
| - 'Time Counts' launches as a social media-led video series asking the global community to collectively give 1 million minutes to better support carers
- Embracing Carers, a global initiative... ► Artikel lesen | ||||
| PFIZER | 38,20 | 0,00 % | Pfizer steht vor dem Umsatzeinbruch - trotzdem solltest du die Aktie mögen | |
| Einige Investitionsentscheidungen scheinen echte Selbstläufer zu sein. Wenn man absehen kann, dass das Umsatzwachstum eines Unternehmens sinken wird, dann lässt man die Aktie lieber links liegen, oder?... ► Artikel lesen | ||||
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von
Nachrichten • Aktienkurse • DAX • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer | Datenschutz • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
